Quiz: Remission Duration in R/R FL After Multiple Lines of Therapy

07/29/2021

Recent News

News

Ivonescimab Plus Liposomal Irinotecan Demonstrates Second-Line Promise in Small Cell Lung Cancer

06/09/2026

Emily Estrada

Results from a phase 2 study demonstrate that ivonescimab plus liposomal irinotecan shows encouraging efficacy and safety in pretreated patients with small cell lung cancer.

Results from a phase 2 study...

06/09/2026

Oncology

News

177Lu-Satoreotide Tetraxetan Shows Strong Preliminary Efficacy and Safety in Extensive-Stage Small Cell Lung Cancer

06/09/2026

Emily Estrada

Results from the phase 1 LuSato-1 study suggest that combining maintenance immunotherapy with 177Lu-satoreotide tetraxetan demonstrates promising preliminary clinical efficacy and safety in patients with in extensive-stage small cell lung...

Results from the phase 1...

06/09/2026

Oncology

News

Autologous NK Cell Consolidation Improves Survival Outcomes in Limited-Stage Small Cell Lung Cancer

06/09/2026

Emily Estrada

Results from a phase 2 study demonstrated that autologous NK cell consolidation following chemoradiotherapy significantly improved survival in patients with limited-stage small cell lung cancer.

Results from a phase 2 study...

06/09/2026

Oncology

News

New Conceptual Model Captures Patient Experience in Polycythemia Vera

06/08/2026

Stephanie Holland

Results from a qualitative study demonstrated that patients with polycythemia vera experience substantial symptom burden and quality-of-life impairment.

Results from a qualitative study...

06/08/2026

Oncology

News

Real-World Analysis Identifies Challenges With Phlebotomy-Based Management of Polycythemia Vera

06/08/2026

Stephanie Holland

Results from a retrospective real-world analysis demonstrated that phlebotomy remains widely used in the management of polycythemia vera, despite substantial treatment burden and challenges achieving durable hematocrit control.

Results from a retrospective...

06/08/2026

Oncology

News

Higher Starting Dose of Ropeginterferon Accelerates Responses in Patients With Polycythemia Vera

06/08/2026

Stephanie Holland

Results from a systematic review and meta-analysis demonstrated that high initial dose and accelerated titration of ropeginterferon was associated with faster hematologic and molecular responses in patients with polycythemia vera.

Results from a systematic review...

06/08/2026

Oncology

News

Varegacestat Demonstrates Strong Clinical Promise in Patients With Desmoid Tumors

06/08/2026

Emily Estrada

Results from the phase 3 RINGSIDE trial demonstrated that varegacestat significantly improved outcomes compared with placebo in patients with progressive desmoid tumors.

Results from the phase 3...

06/08/2026

Oncology

News

Nirogacestat Demonstrates Encouraging Real-World Activity in Patients With Desmoid Tumors

06/08/2026

Emily Estrada

Results from a retrospective real-world analysis demonstrated that nirogacestat improved response compared to other commonly used systemic therapies in patients with desmoid tumors.

Results from a retrospective...

06/08/2026

Oncology

News

Eganelisib Demonstrates Early Activity in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

06/05/2026

Emily Estrada

Results from a phase 1 study demonstrated that eganelisib showed promising preliminary activity in heavily pretreated patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes.

Results from a phase 1 study...

06/05/2026

Oncology

News

Fedratinib Demonstrates Potential Clinical Promise in Patients With Proliferative MDS/MPNs and Chronic Neutrophilic Leukemia

06/05/2026

Emily Estrada

Results from a phase 2 study demonstrated that fedratinib showed promising clinical activity among patients with myelodysplastic and myeloproliferative neoplasms and chronic neutrophilic leukemia.

Results from a phase 2 study...

06/05/2026

Oncology